NCT03725761 2025-05-13Sacituzumab Govitecan in Patients With Metastatic Castration-Resistant Prostate Cancer Progressing on Second Generation AR-Directed TherapyUniversity of Wisconsin, MadisonPhase 2 Active not recruiting31 enrolled 12 charts